The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Blueprint Medicines Corporation(NASDAQ:BPMC) 
Blueprint Medicines Corporation, a precision therapy company, develops medicines for people with cancer and hematologic disorders, and multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy in the United States and Europe. The company is developing avaprit...
Website: http://www.blueprintmedicines.com
Founded: 2008
Full Time Employees: 420
Sector: Healthcare
Industry: Biotechnology
Blueprint Medicines Days Payable Outstanding ttm (DPO)
Blueprint Medicines Days Receivable Outstanding ttm (DSO)
Blueprint Medicines Days Inventory Outstanding ttm (DIO)
Blueprint Medicines Op Cashflow Per Share ttm
Blueprint Medicines Free Cashflow Per Share ttm
Blueprint Medicines Cash Per Share ttm
Blueprint Medicines P/S ratio ttm
Blueprint Medicines (GAAP) P/E ratio ttm
Blueprint Medicines P/B ratio ttm
No extra charts and metrics for this ticker.